Partner David Simon was featured in a Compliance & Ethics article, “Compliance Challenges in India: Why Your Program May Not Translate,” in advance of the Annual Compliance & Ethics Institute where Simon will participate in a panel on the same topic. The article featured a whistleblower scenario and walked through suggested steps in-house counsel, outside U.S. counsel and Indian counsel may take to evaluate the issue. Simon provided insights from an outside counsel perspective and said, “I understand the real and legitimate morale and disruption concerns this scenario raises … I would recommend taking a few reasonable, but tailored investigative steps to test the ‘corrupt sales agent’ allegation.”
Author(s)
Related Insights
21 October 2024
Events
Legal Overview of the BIOSECURE Act
Foley special counsel John Strom is speaking in the Association for Accessible Medicine’s GRx+Biosims 2024 conference in a panel titled “Legal Overview of the BIOSECURE Act” on October 21.
04 October 2024
Innovative Technology Insights
Decoding California’s Recent Flurry of AI Laws
Governor Newsom signed over 18 AI-related bills into law during September, impacting numerous industries.
17 October 2024
Events
Top Compliance Considerations when Commercializing in the U.S.
Kyle Faget and Nathan "Nate" Beaver, co-chair of Foley's Medical Device and Equipment Area of Focus within the firm's Health Care & Life Sciences Sector, invite you to join us for a webinar on the compliance considerations you need to know when you are commercializing your medical device products in the U.S.